ES8603870A1 - Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. - Google Patents

Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.

Info

Publication number
ES8603870A1
ES8603870A1 ES538256A ES538256A ES8603870A1 ES 8603870 A1 ES8603870 A1 ES 8603870A1 ES 538256 A ES538256 A ES 538256A ES 538256 A ES538256 A ES 538256A ES 8603870 A1 ES8603870 A1 ES 8603870A1
Authority
ES
Spain
Prior art keywords
compounds
iminobisethanol
derivatives
useful
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES538256A
Other languages
English (en)
Other versions
ES538256A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of ES538256A0 publication Critical patent/ES538256A0/es
Publication of ES8603870A1 publication Critical patent/ES8603870A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA PREPARACION DE DERIVADOS DE 2,2K-IMINOBISETANOL. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III), EN PRESENCIA DE UNA BASE, EN UN DISOLVENTE INERTE COMO, UN HIDROCARBURO AROMATICO, UN ALCANOL INFERIOR U OTROS, A UNA TEMPERATURA ELEVADA, PARA OBTENER UN COMPUESTO DE FORMULA (I). SIENDO: A1 Y A2, UN ENLACE DIRECTO, -CH2-; D1, RADICAL DE FORMULA (IV); D2, RADICAL DE FORMULA (V); Q1, RADICAL -NHR1; Q2, RADICAL -W, GRUPO SALIENTE REACTIVO; R1, H, ALQUILO DE C 1 A 6, ARILO U OTROS; R2 Y R3, H, (ALQUIL DE C 1 A 12) CARBONILO O ARLCARBONILO; R4, R5, R6 Y R7, H O ALQUILO DE C 1 A 6; R8 Y R9, H O EL RADICAL -A1-CHR8-; Y R10 A R17, H, HAL, ALQUILO DE C 1 A 6, ALQUENILO DE C 2 A 6 U OTROS. SE UTILIZA EN EL TRATAMIENTO DE LOS TRANSTORNOS DEL SISTEMA VASCULAR CORONARIO.
ES538256A 1983-12-05 1984-12-04 Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. Expired ES8603870A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55808183A 1983-12-05 1983-12-05

Publications (2)

Publication Number Publication Date
ES538256A0 ES538256A0 (es) 1986-01-01
ES8603870A1 true ES8603870A1 (es) 1986-01-01

Family

ID=24228139

Family Applications (1)

Application Number Title Priority Date Filing Date
ES538256A Expired ES8603870A1 (es) 1983-12-05 1984-12-04 Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.

Country Status (32)

Country Link
EP (1) EP0145067B1 (es)
JP (1) JPS60132977A (es)
KR (1) KR870000923B1 (es)
AR (1) AR241414A1 (es)
AT (1) ATE40361T1 (es)
AU (1) AU573658B2 (es)
BG (1) BG43866A3 (es)
CA (1) CA1337429C (es)
CS (1) CS250242B2 (es)
CY (1) CY1609A (es)
DD (1) DD235453A5 (es)
DE (1) DE3476388D1 (es)
DK (2) DK165112C (es)
DZ (1) DZ712A1 (es)
ES (1) ES8603870A1 (es)
FI (1) FI82460C (es)
GR (1) GR81098B (es)
HK (1) HK52791A (es)
HU (1) HU202219B (es)
IE (1) IE57831B1 (es)
IL (1) IL73706A (es)
MA (1) MA20292A1 (es)
NO (2) NO169839C (es)
NZ (1) NZ210388A (es)
PH (1) PH22432A (es)
PL (1) PL146342B1 (es)
PT (1) PT79609B (es)
RO (1) RO91184B (es)
SG (1) SG47091G (es)
SU (1) SU1428199A3 (es)
ZA (1) ZA849445B (es)
ZW (1) ZW19784A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02103116U (es) * 1989-02-01 1990-08-16
JPH02218675A (ja) * 1989-02-21 1990-08-31 Nippon Kayaku Co Ltd ６―フルオロクロモン―２―カルボン酸及びその製造法
TW199152B (es) * 1990-11-01 1993-02-01 Takeda Pharm Industry Co Ltd
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
DE69524528T2 (de) * 1994-10-14 2002-08-01 Merck Patent Gmbh ZNS wirksames (R)-(-)-2-[5-(4-Fluorophenyl)-3-pyridylmethylaminomethyl]chroman
WO1999032476A1 (en) * 1997-12-19 1999-07-01 Bayer Corporation Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
US6541669B1 (en) 1998-06-08 2003-04-01 Theravance, Inc. β2-adrenergic receptor agonists
US6713651B1 (en) 1999-06-07 2004-03-30 Theravance, Inc. β2-adrenergic receptor agonists
US6683115B2 (en) 1999-06-02 2004-01-27 Theravance, Inc. β2-adrenergic receptor agonists
US6593497B1 (en) 1999-06-02 2003-07-15 Theravance, Inc. β2-adrenergic receptor agonists
UA73965C2 (en) 1999-12-08 2005-10-17 Theravance Inc b2 ADRENERGIC RECEPTOR ANTAGONISTS
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
EP1406608B1 (en) 2001-05-02 2009-07-29 Nitromed, Inc. Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
JP2004538289A (ja) 2001-07-26 2004-12-24 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング ２−［５−（４−フルオロフェニル）−３−ピリジルメチルアミノメチル］−クロマンおよびその生理学的に許容し得る塩の新規な使用
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
WO2003042160A1 (en) 2001-11-13 2003-05-22 Theravance, Inc. Aryl aniline beta-2 adrenergic receptor agonists
EP1741712B1 (en) * 2004-07-30 2011-06-15 Torrent Pharmaceuticals Ltd amorphous form of nebivolol hydrochloride and its preparation
DE602004026789D1 (de) * 2004-08-11 2010-06-02 Hetero Drugs Ltd Neues verfahren zur herstellung von nebivololzwischenprodukten
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
AP2764A (en) * 2005-01-31 2013-09-30 Mylan Lab Inc Hydroxylated nebivolol metabolites
EP1850842A1 (de) * 2005-02-11 2007-11-07 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
AT502220A1 (de) * 2005-07-19 2007-02-15 Pharmacon Forschung & Beratung Verfahren zur herstellung von nebivolol
US7560575B2 (en) * 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
WO2007083318A1 (en) 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
ES2346371T3 (es) 2006-11-27 2010-10-14 Zach System S.P.A. Proceso para la preparacion de nebivolol.
CA2675538C (en) 2007-01-22 2017-02-28 Genpharm Ulc Oral pharmaceutical compositions comprising unmicronized nebivolol or a nebivolol analogue as active ingredient, and a decreased ratio of wetting agent to active ingredient
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1392067B1 (it) * 2008-10-31 2012-02-09 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
EP2907809B1 (en) 2014-02-14 2018-08-22 Corden Pharma International GmbH Base-free process for the preparation of ketone intermediates usable for manufacture of nebivolol
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
KR20230068441A (ko) 2015-05-19 2023-05-17 저장 아우선 파마슈티칼 씨오., 엘티디. 네비볼롤 합성방법 및 그의 중간 화합물
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1054655A (es) * 1964-01-24
US4313955A (en) * 1980-10-14 1982-02-02 Ciba-Geigy Corporation 1,5-Bis(1,4-benzodioxin-2-yl)-3-azapentane-1,5-diols
GB8418472D0 (en) * 1984-07-19 1984-08-22 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
DK11892A (da) 1992-01-31
MA20292A1 (fr) 1985-07-01
AR241414A1 (es) 1992-07-31
RO91184A (ro) 1987-07-30
FI844777L (fi) 1985-06-06
PH22432A (en) 1988-09-12
NO2004007I2 (no) 2005-05-09
EP0145067A3 (en) 1986-03-26
EP0145067B1 (en) 1989-01-25
ATE40361T1 (de) 1989-02-15
AU3632684A (en) 1985-06-13
DZ712A1 (fr) 2004-09-13
HK52791A (en) 1991-07-19
HUT37418A (en) 1985-12-28
DK577084A (da) 1985-06-06
SU1428199A3 (ru) 1988-09-30
ZA849445B (en) 1986-07-30
IL73706A0 (en) 1985-03-31
EP0145067A2 (en) 1985-06-19
RO91184B (ro) 1987-07-31
NO844845L (no) 1985-06-06
KR870000923B1 (ko) 1987-05-07
PT79609A (en) 1985-01-01
DK11892D0 (da) 1992-01-31
DE3476388D1 (en) 1989-03-02
CS250242B2 (en) 1987-04-16
IE843103L (en) 1985-06-05
DK165112C (da) 1993-03-01
ES538256A0 (es) 1986-01-01
NO2004007I1 (no) 2004-12-20
DK577084D0 (da) 1984-12-04
NO169839C (no) 1992-08-12
HU202219B (en) 1991-02-28
DK165321B (da) 1992-11-09
JPH0250114B2 (es) 1990-11-01
NO169839B (no) 1992-05-04
FI844777A0 (fi) 1984-12-04
PL250524A1 (en) 1986-02-25
AU573658B2 (en) 1988-06-16
CA1337429C (en) 1995-10-24
SG47091G (en) 1991-07-26
DK165321C (da) 1993-03-29
BG43866A3 (en) 1988-08-15
DD235453A5 (de) 1986-05-07
PL146342B1 (en) 1989-01-31
PT79609B (en) 1986-12-12
CY1609A (en) 1992-04-03
JPS60132977A (ja) 1985-07-16
FI82460B (fi) 1990-11-30
IL73706A (en) 1988-07-31
DK165112B (da) 1992-10-12
ZW19784A1 (en) 1986-07-02
GR81098B (en) 1984-12-17
IE57831B1 (en) 1993-04-21
KR850004485A (ko) 1985-07-15
FI82460C (fi) 1991-03-11
NZ210388A (en) 1987-07-31

Similar Documents

Publication Publication Date Title
ES8603870A1 (es) Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol.
ES8602763A1 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
ES8604203A1 (es) Un procedimiento para la preparacion de nuevas-n-heterociclil-4-piperidinaminas.
ES8706668A1 (es) Un procedimiento para la preparacion de derivados de piperidina.
ES8601965A1 (es) Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona
IL74707A0 (en) Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation
IL92730A (en) 2-aminopyrimidinone derivatives, their preparation and pharmaceutical compositions containing them
UA27749C2 (uk) Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі
AU2232288A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl) benzamides
GR3004114T3 (es)
ES8506616A1 (es) Un procedimiento para la preparacion de carboxamidas
IL97892A0 (en) 2,9-disubstituted-4h-pyrido(1,2-a)pyrimidin-4-ones,their preparation and pharmaceutical compositions containing them
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
HUT51622A (en) Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050920